GoHealth, Inc. (NASDAQ:GOCO) Short Interest Down 8.7% in January

GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 129,400 shares, a decline of 8.7% from the December 31st total of 141,700 shares. Currently, 1.6% of the company's shares are sold short. Based on an average daily volume of 38,900 shares, the days-to-cover ratio is presently 3.3 days.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reiterated a "sector perform" rating and set a $13.00 price objective on shares of GoHealth in a research note on Monday, October 21st.

Hedge Funds Weigh In On GoHealth

A number of hedge funds have recently added to or reduced their stakes in GOCO. Empowered Funds LLC boosted its stake in GoHealth by 5.1% in the third quarter. Empowered Funds LLC now owns 22,048 shares of the company's stock valued at $207,000 after acquiring an additional 1,072 shares during the period. Geode Capital Management LLC boosted its position in GoHealth by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company's stock valued at $973,000 after purchasing an additional 3,205 shares during the period. Renaissance Technologies LLC grew its stake in GoHealth by 22.0% during the 2nd quarter. Renaissance Technologies LLC now owns 18,272 shares of the company's stock worth $178,000 after buying an additional 3,300 shares during the last quarter. JPMorgan Chase & Co. increased its position in GoHealth by 99.3% in the third quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company's stock worth $79,000 after buying an additional 4,204 shares during the period. Finally, Barclays PLC lifted its stake in GoHealth by 83.9% in the third quarter. Barclays PLC now owns 9,580 shares of the company's stock valued at $89,000 after buying an additional 4,372 shares during the last quarter. Institutional investors and hedge funds own 24.21% of the company's stock.

GoHealth Stock Down 1.3 %

Shares of GOCO stock traded down $0.21 during mid-day trading on Wednesday, reaching $16.22. 16,950 shares of the company were exchanged, compared to its average volume of 58,763. The company has a market capitalization of $371.60 million, a P/E ratio of -4.63 and a beta of 1.67. The business's 50 day simple moving average is $13.61 and its 200 day simple moving average is $11.46. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. GoHealth has a fifty-two week low of $7.27 and a fifty-two week high of $18.20.

GoHealth (NASDAQ:GOCO - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($3.73) earnings per share for the quarter, missing the consensus estimate of ($3.19) by ($0.54). GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. The company had revenue of $118.29 million during the quarter, compared to the consensus estimate of $105.93 million. During the same period in the previous year, the firm posted ($2.61) EPS. Research analysts predict that GoHealth will post -5.5 earnings per share for the current year.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.